SNES
Senestech Inc
$
5.160
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
5.5282
Open
5.410
VWAP
5.21
Vol
168.36K
Mkt Cap
9.33M
Low
5.070
Amount
876.94K
EV/EBITDA(TTM)
--
Total Shares
5.14M
EV
8.28M
EV/OCF(TTM)
--
P/S(TTM)
2.16
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q4
FY2024Q3
FY2024Q2
707.00K
+139.66%
--
--
582.00K
+61.67%
--
--
485.00K
+59.02%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for SenesTech, Inc. (SNES) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 103.95%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+103.95%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Senestech Inc (SNES.O) is -0.99, compared to its 5-year average forward P/E of -11.67. For a more detailed relative valuation and DCF analysis to assess Senestech Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-11.67
Current PE
-0.99
Overvalued PE
34.22
Undervalued PE
-57.55
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-0.40
Current EV/EBITDA
-3.99
Overvalued EV/EBITDA
0.36
Undervalued EV/EBITDA
-1.16
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
5.69
Current PS
4.39
Overvalued PS
12.77
Undervalued PS
-1.39
Financials
Annual
Quarterly
FY2025Q1
YoY :
+16.87%
485.00K
Total Revenue
FY2025Q1
YoY :
-9.77%
-1.66M
Operating Profit
FY2025Q1
YoY :
-9.12%
-1.67M
Net Income after Tax
FY2025Q1
YoY :
-64.04%
-1.28
EPS - Diluted
FY2025Q1
YoY :
-13.00%
-1.59M
Free Cash Flow
FY2025Q1
YoY :
+98.40%
64.54
Gross Profit Margin - %
FY2025Q1
YoY :
-44.29%
-305.09
FCF Margin - %
FY2025Q1
YoY :
-22.23%
-343.30
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SNES News & Events
Events Timeline
2025-08-05 (ET)
2025-08-05
08:08:09
SenesTech announces warrant exercise for $6.3M in gross proceeds
2025-07-01 (ET)
2025-07-01
08:02:13
SenesTech exercises warrants for $4.4M in gross proceeds
2025-06-26 (ET)
2025-06-26
08:04:07
SenesTech's Evolve rodent birth control tested in Hong Kong, San Francisco
Sign Up For More Events
Sign Up For More Events
News
8.5
08-05Yahoo FinancePinnedSenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds
8.5
08-05PRnewswirePinnedSenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds
8.5
07-01NewsfilterSenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds
Sign Up For More News
People Also Watch
TCRT
Alaunos Therapeutics Inc
2.840
USD
-3.40%
AUUD
Auddia Inc
2.900
USD
-20.77%
TIVC
Tivic Health Systems Inc
3.319
USD
-1.80%
XXII
22nd Century Group Inc
2.490
USD
-2.35%
NVVE
Nuvve Holding Corp
0.542
USD
-0.55%
ASST
Asset Entities Inc
3.500
USD
+0.29%
DRMA
Dermata Therapeutics Inc
6.520
USD
-6.72%
HSDT
Helius Medical Technologies Inc
5.550
USD
-5.93%
SYTA
Siyata Mobile Inc
3.710
USD
-1.59%
FAQ
What is Senestech Inc (SNES) stock price today?
The current price of SNES is 5.16 USD — it has decreased -3.73 % in the last trading day.
What is Senestech Inc (SNES)'s business?
What is the price predicton of SNES Stock?
What is Senestech Inc (SNES)'s revenue for the last quarter?
What is Senestech Inc (SNES)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Senestech Inc (SNES)'s fundamentals?
How many employees does Senestech Inc (SNES). have?